Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-126 Gel in Acne Vulgaris
NCT04214639Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of clindamycin phosphate + adapalene + benzoyl peroxide in acne vulgaris, sponsored by Valeant Pharmaceuticals. Started Jan 2020; status: completed.
02
Drugs
clindamycin phosphate + adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04214639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04214639.